These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 25699610)

  • 1. Polymorphisms in prothrombotic genes in young stroke patients in Greece: a case-controlled study.
    Ranellou K; Paraskeva A; Kyriazopoulos P; Batistatou A; Evangelou A; El-Aly M; Zis P; Tavernarakis A; Charalabopoulos K
    Blood Coagul Fibrinolysis; 2015 Jun; 26(4):430-5. PubMed ID: 25699610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasminogen activator inhibitor-1, factor V, factor II and methylenetetrahydrofolate reductase polymorphisms in women with recurrent miscarriage.
    Pietropolli A; Giuliani E; Bruno V; Patrizi L; Piccione E; Ticconi C
    J Obstet Gynaecol; 2014 Apr; 34(3):229-34. PubMed ID: 24484533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of classic risk factors and prothrombotic factor gene mutations in ischemic stroke risk development in young and middle-aged individuals.
    Supanc V; Sonicki Z; Vukasovic I; Solter VV; Zavoreo I; Kes VB
    J Stroke Cerebrovasc Dis; 2014 Mar; 23(3):e171-6. PubMed ID: 24189452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphisms associated with retinal vein occlusion: a Greek case-control study and meta-analysis.
    Yioti GG; Panagiotou OA; Vartholomatos GA; Kolaitis NI; Pappa CN; Evangelou E; Stefaniotou MI
    Ophthalmic Genet; 2013 Sep; 34(3):130-9. PubMed ID: 23289804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association of factor V G1961A (factor V Leiden), prothrombin G20210A, MTHFR C677T and PAI-1 4G/5G polymorphisms with recurrent pregnancy loss in Bosnian women.
    Jusić A; Balić D; Avdić A; Pođanin M; Balić A
    Med Glas (Zenica); 2018 Aug; 15(2):158-163. PubMed ID: 29703881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The plasminogen activator inhibitor (PAI-1) 4G/5G promoter polymorphism and PAI-1 levels in ischemic stroke. A case-control study.
    van Goor ML; Gómez García E; Leebeek F; Brouwers GJ; Koudstaal P; Dippel D
    Thromb Haemost; 2005 Jan; 93(1):92-6. PubMed ID: 15630497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasminogen activator inhibitor-1 4G/5G polymorphism, factor V Leiden, prothrombin mutations and the risk of VTE recurrence.
    Sundquist K; Wang X; Svensson PJ; Sundquist J; Hedelius A; Larsson Lönn S; Zöller B; Memon AA
    Thromb Haemost; 2015 Nov; 114(6):1156-64. PubMed ID: 26245493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variant alleles in factor V, prothrombin, plasminogen activator inhibitor-1, methylenetetrahydrofolate reductase and risk of thromboembolism in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab.
    Falvella FS; Cremolini C; Miceli R; Nichetti F; Cheli S; Antoniotti C; Infante G; Martinetti A; Marmorino F; Sottotetti E; Berenato R; Caporale M; Colombo A; de Braud F; Di Bartolomeo M; Clementi E; Loupakis F; Pietrantonio F
    Pharmacogenomics J; 2017 Jul; 17(4):331-336. PubMed ID: 27001121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between plasminogen activator inhibitor 1 gene polymorphisms and preeclampsia.
    Fabbro D; D'Elia AV; Spizzo R; Driul L; Barillari G; Di Loreto C; Marchesoni D; Damante G
    Gynecol Obstet Invest; 2003; 56(1):17-22. PubMed ID: 12867763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of genetic polymorphisms and diabetes mellitus on the development of peripheral artery disease.
    Yalım Z; Tutgun Onrat S; Alan S; Aldemir M; Avşar A; Doğan İ; Onrat E
    Turk Kardiyol Dern Ars; 2020 Jul; 48(5):484-493. PubMed ID: 32633259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cilioretinal artery: Vasculogenesis might be promoted by plasminogen activator inhibitor-1 5G allele.
    Yilmaz S; Ardagil A; Akalin I; Altinel MG; Dag Y; Kurum E; Koyun E; Ari Yaylali S; Bayramlar H
    Ophthalmic Genet; 2017; 38(5):428-433. PubMed ID: 28145780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Plasminogen activator inhibitor type 1 activity in women with unexplained very early recurrent pregnancy loss].
    Ivanov P; Komsa-Penkova R; Ivanov I; Konova E; Kovacheva K; Simeonova M; Tanchev S
    Akush Ginekol (Sofiia); 2010; 49(5):3-8. PubMed ID: 21268395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasminogen activator inhibitor-1 (PAI-1) gene 4G/5G promoter polymorphism is seen in higher frequency in the Indian patients with deep vein thrombosis.
    Akhter MS; Biswas A; Ranjan R; Meena A; Yadav BK; Sharma A; Saxena R
    Clin Appl Thromb Hemost; 2010 Apr; 16(2):184-8. PubMed ID: 19419975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasminogen activator inhibitor 1 4G/5G polymorphism and coagulation factor XIII Val34Leu polymorphism: impaired fibrinolysis and early pregnancy loss.
    Dossenbach-Glaninger A; van Trotsenburg M; Dossenbach M; Oberkanins C; Moritz A; Krugluger W; Huber J; Hopmeier P
    Clin Chem; 2003 Jul; 49(7):1081-6. PubMed ID: 12816904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ABO blood group but not haemostasis genetic polymorphisms significantly influence thrombotic risk: a study of 180 homozygotes for the Factor V Leiden mutation.
    Procare-GEHT Group
    Br J Haematol; 2006 Dec; 135(5):697-702. PubMed ID: 17107352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Association of genetic polymorphisms in plasminogen activator inhibitor-1 gene and 5,10-methylenetetrahydrofolate reductase gene with recurrent early spontaneous abortion].
    Guan LX; Du XY; Wang JX; Gao L; Wang RL; Li HB; Wang SX
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Jun; 22(3):330-3. PubMed ID: 15952129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Major and potential prothrombotic genotypes in patients with venous thrombosis and in healthy subjects from Slovenia.
    Bedencic M; Bozic M; Peternel P; Stegnar M
    Pathophysiol Haemost Thromb; 2008; 36(2):58-63. PubMed ID: 19127083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevalence of thrombophilic mutations of FV Leiden, prothrombin G20210A and PAl-1 4G/5G and their combinations in a group of 1450 healthy middle-aged individuals in the Prague and Central Bohemian regions (results of FRET real-time PCR assay)].
    Kvasnicka J; Hájková J; Bobcíková P; Kvasnicka T; Dusková D; Poletínová S; Kieferová V
    Cas Lek Cesk; 2012; 151(2):76-82. PubMed ID: 22515013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of PAI-1 4G/5G and -844G/A gene polymorphism and changes in PAI-1/tPA levels in stroke: a case-control study.
    Saidi S; Slamia LB; Mahjoub T; Ammou SB; Almawi WY
    J Stroke Cerebrovasc Dis; 2007; 16(4):153-9. PubMed ID: 17689411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prothrombin polymorphism A19911G, factor V HR2 haplotype A4070G, and plasminogen activator-inhibitor-1 polymorphism 4G/5G and the risk of retinal vein occlusion.
    Kuhli-Hattenbach C; Hellstern P; Nägler DK; Kohnen T; Hattenbach LO
    Ophthalmic Genet; 2017; 38(5):413-417. PubMed ID: 28085526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.